{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:12:39Z","timestamp":1761027159338,"version":"build-2065373602"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Major Facilitator Superfamily Domain-containing 12 (MFSD12) has emerged as a critical transmembrane protein with increasingly recognized roles in various cancers. The complex pathogenesis and therapeutic resistance of liver hepatocellular carcinoma (LIHC) present significant clinical challenges. This study investigates MFSD12\u2019s potential involvement in LIHC progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>We performed an extensive pan-cancer analysis of MFSD12 utilizing integrated datasets from The Cancer Genome Atlas (TCGA), the Gene Expression Omnibus (GEO), and the ArrayExpress database. Our investigation focused on evaluating its prognostic significance, clinical implications, associated signaling pathways, immune cell infiltration, gene mutations, and sensitivity to chemotherapeutic agents. Through the application of R and various online analytical tools, our study demonstrated that MFSD12 expression levels were significantly higher in LIHC compared to other cancer types within the TCGA pan-cancer dataset. This finding highlights the specificity of MFSD12 expression in LIHC, a conclusion further validated by immunohistochemical analysis. Survival analysis indicated that this upregulation is associated with unfavorable clinical outcomes. Furthermore, single-cell RNA sequencing revealed that MFSD12 was predominantly expressed in tumor cells and innate lymphoid cells (ILCs) within the tumor microenvironment. Functional vitro studies showed MFSD12-siRNA treatment effectively suppressed LIHC cell proliferation, migration, and invasion. Mechanistically, MFSD12-siRNA enhanced E-cadherin while reducing vimentin, MMP-2, and MMP-9 levels. Further analyses revealed significant associations between MFSD12 expression and immune infiltration, immune checkpoint molecules, tumor mutation burden, and microsatellite instability in LIHC. Notably, MFSD12-siRNA decreased HAVCR2(TIM3) and its ligand galectin-9 (LGALS9) expression in LIHC cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings demonstrated that MFSD12 upregulation in LIHC strongly correlates with poor prognosis. This association was potentially attributed to MFSD12\u2019s dual roles: promoting tumor cell proliferation, migration, and metastasis while critically modulating the tumor immune microenvironment, particularly through interaction with the HAVCR2\/LGALS9 immune checkpoint axis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1681887","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:37:04Z","timestamp":1761025024000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["MFSD12 promotes proliferation, metastasis and invasion of hepatocellular carcinoma cells and its potential correlation with HAVCR2\/LGALS9 immune checkpoint axis"],"prefix":"10.3389","volume":"16","author":[{"given":"Kai","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-run","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","article-title":"Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jes.2022.05.037","article-title":"Air pollution and liver cancer: A systematic review","volume":"126","author":"Gan","year":"2023","journal-title":"J Environ Sci (China)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01527-8","article-title":"Metabolic reprogramming in the tumor microenvironment of liver cancer","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s43556-024-00184-0","article-title":"Signaling pathways in liver cancer: pathogenesis and targeted therapy","volume":"5","author":"Xue","year":"2024","journal-title":"Mol Biomed"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000005","article-title":"Metabolic reprogramming and its clinical implication for liver cancer","volume":"78","author":"Yang","year":"2023","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(23)00111-5","article-title":"Fibroblasts in liver cancer: functions and therapeutic translation","volume":"8","author":"Affo","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11908","DOI":"10.3390\/ijms231911908","article-title":"Non-coding RNA related to MAPK signaling pathway in liver cancer","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"154913","DOI":"10.1016\/j.prp.2023.154913","article-title":"MicroRNAs as the critical regulators of tumor angiogenesis in liver cancer","volume":"251","author":"Fanoodi","year":"2023","journal-title":"Pathol Res Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"188848","DOI":"10.1016\/j.bbcan.2022.188848","article-title":"Ferroptosis and its interaction with tumor immune microenvironment in liver cancer","volume":"1878","author":"Huang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1323581","article-title":"The current status and future of PD-L1 in liver cancer","volume":"14","author":"Hao","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1230465","article-title":"Post-translational modifications and immune responses in liver cancer","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1787152","article-title":"Heterogeneity in liver cancer immune microenvironment: emerging single-cell and spatial perspectives","volume":"44","author":"Li","year":"2024","journal-title":"Semin Liver Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S349426","article-title":"Advances in nanoliposomes for the diagnosis and treatment of liver cancer","volume":"17","author":"Li","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00821-z","article-title":"Friend or foe? The elusive role of hepatic stellate cells in liver cancer","volume":"20","author":"Cogliati","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"216048","DOI":"10.1016\/j.canlet.2022.216048","article-title":"Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy","volume":"555","author":"Chen","year":"2023","journal-title":"Cancer Lett"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2240031","DOI":"10.1080\/19490976.2023.2240031","article-title":"Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions","volume":"15","author":"Rajapakse","year":"2023","journal-title":"Gut Microbes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-024-00919-y","article-title":"Artificial intelligence in liver cancer - new tools for research and patient management","volume":"21","author":"Calderaro","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2937-x","article-title":"MFSD12 mediates the import of cysteine into melanosomes and lysosomes","volume":"588","author":"Adelmann","year":"2020","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0531-6","article-title":"Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma","volume":"38","author":"Wei","year":"2019","journal-title":"Oncogene"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwaf077","article-title":"MFSD12 affects glycosphingolipid metabolism by modulating lysosome homeostasis","volume":"14","author":"Hong","year":"2023","journal-title":"Protein Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00014.2024","article-title":"MFSD12 depletion reduces cystine accumulation without improvement in proximal tubular function in experimental models for cystinosis","volume":"326","author":"Bondue","year":"2024","journal-title":"Am J Physiol Renal Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1398320","article-title":"The emerging role and clinicopathological significance of MFSD12 in cancer and lysosomal storage diseases","volume":"15","author":"Ding","year":"2024","journal-title":"Front Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets\u2013update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2013non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3791\/62528","article-title":"Three differential expression analysis methods for RNA sequencing: limma, edgeR, DESeq2","volume":"175","author":"Liu","year":"2021","journal-title":"J Vis Exp"},{"key":"B35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab972","article-title":"EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study","volume":"50","author":"Xiong","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13072-019-0316-3","article-title":"The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization","volume":"12","author":"Li","year":"2019","journal-title":"Epigenet Chromatin"},{"key":"B40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1055","article-title":"The Gene Ontology Resource: 20 years and still GOing strong","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-0327-7_16","article-title":"Immunedeconv: an R package for unified access to computational methods for estimating immune cell fractions from bulk RNA-sequencing data","volume":"2120","author":"Sturm","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1038\/psp.2013.56","article-title":"Application of ggplot2 to pharmacometric graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J Cell Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.024","article-title":"EMT: matter of life or death","volume":"164","author":"Gupta","year":"2016","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.5556","article-title":"Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer","volume":"27","author":"Roy","year":"2009","journal-title":"J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"104452","DOI":"10.1016\/j.ebiom.2023.104452","article-title":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","volume":"88","author":"Mezheyeuski","year":"2023","journal-title":"EBioMedicine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0433-3","article-title":"Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia","volume":"33","author":"Curley","year":"2020","journal-title":"Mod Pathol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2021.04.011","article-title":"The TIM3\/Gal9 signaling pathway: An emerging target for cancer immunotherapy","volume":"510","author":"Kandel","year":"2021","journal-title":"Cancer Lett"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1681887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T05:37:06Z","timestamp":1761025026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1681887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2025.1681887"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1681887","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"article-number":"1681887"}}